SARA BLANKENSHIP: Open Payments
NPI 1811518780 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,442 in 148 payments from 24 companies in 2025. Trend: 2023 $2,281 · 2024 $2,749 · 2025 $2,442
Food & beverage: $2,442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $526 |
| Axsome Therapeutics, Inc. | 12 | $404 |
| AstraZeneca Pharmaceuticals LP | 9 | $172 |
| PFIZER INC. | 11 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $161 |
| Amgen Inc. | 11 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $89 |
| Lilly USA, LLC | 5 | $87 |
| Novo Nordisk Inc | 4 | $77 |
Products named: Auvelity, QULIPTA, TRINTELLIX, NURTEC ODT, VRAYLAR, Kerendia, AIRSUPRA, OTEZLA.
Industry payments across LA — which companies pay providers there.
